AS00.F European Medical Solutions
- Market cap
- EUR 13.9M
- P/E
- 7.1x
- P/B
- 1.04x
- ROE
- 15.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is AS00.F undervalued?
Graham numberAS00.F trades 42.5% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
European Medical Solutions fundamental analysis
No fundamental analysis for European Medical Solutions yet.
European Medical Solutions stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About European Medical Solutions
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally. The company offers ADAM, a software solution for imaging; R/F solutions, including PLATINUM NEO, a solution that revolutionizes the R/F workflow through an interface and AI-powered image processing; OPTIMA, a performance remote-controlled table designed to provide, imaging solution for radiogra…
Full company profileEuropean Medical Solutions financial statements
European Medical Solutions annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 36.3M | 35.3M | 40.6M | 45.1M | 49.9M |
| Gross Profit | 12.1M | 12.3M | 13.5M | 15.0M | 16.4M |
| Operating Income | 28.0K | -1.65M | 18.0K | 1.41M | 2.68M |
| EBITDA | - | -1.25M | 2.02M | 3.77M | 4.83M |
| Net Income | -241K | -5.58M | -709K | 546K | 1.84M |
| EPS | -3.87 | -1.32 | -0.17 | 0.13 | 0.43 |
| Balance Sheet | |||||
| Total Assets | 36.3M | 39.9M | 43.8M | 48.5M | 51.8M |
| Total Liabilities | 25.4M | 29.3M | 33.9M | 38.1M | 39.7M |
| Shareholders' Equity | 10.9M | 10.6M | 9.89M | 10.3M | 12.1M |
| Cash & Short-term Investments | 2.43M | 4.23M | 4.20M | 4.58M | 4.89M |
| Cash Flow | |||||
| Operating Cash Flow | 348K | 2.09M | -2.27M | 2.56M | 5.38M |
| Capital Expenditure | 1.92M | 2.21M | 2.57M | 3.57M | 2.88M |
| Free Cash Flow | -1.57M | -117K | -4.84M | -1.02M | 2.49M |
| Ratios | |||||
| ROE | -2.2% | -52.4% | -7.2% | 5.3% | 15.3% |
| ROA | -0.7% | -14.0% | -1.6% | 1.1% | 3.6% |
| Net Profit Margin | -0.7% | -15.8% | -1.7% | 1.2% | 3.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
European Medical Solutions dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | EUR 521K | 8.38 | - |
| 2017 | - | - | - |
| 2016 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:352 on Dec 27, 2024.
Who owns European Medical Solutions
- Insiders 90.75%
- Institutions 0.02%
- Public & others 9.23%
- Shares outstanding 4.23M
- Free float 445K
European Medical Solutions company profile
- Company name
- European Medical Solutions
- Ticker
- AS00.F
- ISIN
- BE0974497290
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 119
- Fiscal year end
- December
- Address
- Avenue Louise 231, Brussels, Belgium, 1050
- Phone
- 32 4 67 50 49 00
About European Medical Solutions
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally. The company offers ADAM, a software solution for imaging; R/F solutions, including PLATINUM NEO, a solution that revolutionizes the R/F workflow through an interface and AI-powered image processing; OPTIMA, a performance remote-controlled table designed to provide, imaging solution for radiography and fluoroscopy examinations; and Optima, a imaging solution for radiography and fluoroscopy examinations. It also provides bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024. European Medical Solutions was founded in 1997 and is headquartered in Brussels, Belgium. European Medical Solutions is a subsidiary of Diagnostic Medical Systems S.A.
European Medical Solutions management
4- Mr. Samuel SancerniMD, CEO & Chairman
- Ms. Valerie PugnaloniChief Financial Officer
- Mr. Jerome DelanoeChief Operating Officer
- Ms. Nathalie Caire RichardHuman Resource Director